140 related articles for article (PubMed ID: 37465663)
1. Treatment approaches for urachal cancer: Use of immunotherapy and targeted therapies.
Benjamin DJ; Kalebasty AR
Rare Tumors; 2023; 15():20363613231189984. PubMed ID: 37465663
[TBL] [Abstract][Full Text] [Related]
2. Identification of Rare EIF3E::RSPO2 Fusion in Recurrent and Aggressive Urachal Adenocarcinoma.
Jha P; Pengal R; Shah M; Kulkarni PM; Mishra R; Menon N; Vikkath N; Menon S; Ramachandran V; Prakash G; Noronha V; Prabhash K; Kumar P
Genes Chromosomes Cancer; 2024 Jun; 63(6):e23250. PubMed ID: 38884183
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.
Reis H; van der Vos KE; Niedworok C; Herold T; Módos O; Szendrői A; Hager T; Ingenwerth M; Vis DJ; Behrendt MA; de Jong J; van der Heijden MS; Peyronnet B; Mathieu R; Wiesweg M; Ablat J; Okon K; Tolkach Y; Keresztes D; Nagy N; Bremmer F; Gaisa NT; Chlosta P; Kriegsmann J; Kovalszky I; Timar J; Kristiansen G; Radzun HJ; Knüchel R; Schuler M; Black PC; Rübben H; Hadaschik BA; Schmid KW; van Rhijn BWG; Nyirády P; Szarvas T
Int J Cancer; 2018 Oct; 143(7):1764-1773. PubMed ID: 29672836
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma.
Mäkelä R; Arjonen A; Härmä V; Rintanen N; Paasonen L; Paprotka T; Rönsch K; Kuopio T; Kononen J; Rantala JK
BMC Cancer; 2020 Jun; 20(1):590. PubMed ID: 32576176
[TBL] [Abstract][Full Text] [Related]
5. Progress and prospects of targeted therapy and immunotherapy for urachal carcinoma.
Zheng Y; Peng H; Hu X; Ou Y; Wang D; Wang H; Ren S
Front Pharmacol; 2023; 14():1199395. PubMed ID: 37324454
[No Abstract] [Full Text] [Related]
6. Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition.
Collazo-Lorduy A; Castillo-Martin M; Wang L; Patel V; Iyer G; Jordan E; Al-Ahmadie H; Leonard I; Oh WK; Zhu J; McBride RB; Cordon-Cardo C; Solit DB; Sfakianos JP; Galsky MD
Eur Urol; 2016 Nov; 70(5):771-775. PubMed ID: 27178450
[TBL] [Abstract][Full Text] [Related]
7. Imaging of the Urachus: Anomalies, Complications, and Mimics.
Parada Villavicencio C; Adam SZ; Nikolaidis P; Yaghmai V; Miller FH
Radiographics; 2016; 36(7):2049-2063. PubMed ID: 27831842
[TBL] [Abstract][Full Text] [Related]
8. Urachal cancer-current concepts of a rare cancer.
Reis H; Szarvas T
Pathologe; 2019 Jun; 40(Suppl 1):31-39. PubMed ID: 30895340
[TBL] [Abstract][Full Text] [Related]
9. Urachal carcinoma: The journey so far and the road ahead.
Kumar R; Harilal S; Abdelgawad MA; Ghoneim MM; Kumar A; Mathew B
Pathol Res Pract; 2023 Mar; 243():154379. PubMed ID: 36821941
[TBL] [Abstract][Full Text] [Related]
10. A rare cause of urachal adenocarcinoma: urachal diverticle.
Ciçek T; Gönülalan U; Coban G; Erinanç H; Koşan M
Case Rep Urol; 2013; 2013():571395. PubMed ID: 23476880
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable Phenotype.
Kardos J; Wobker SE; Woods ME; Nielsen ME; Smith AB; Wallen EM; Pruthi RS; Hayward MC; McGinty KA; Grilley-Olson JE; Patel NM; Weck KE; Black P; Parker JS; Milowsky MI; Hayes DN; Kim WY
JCO Precis Oncol; 2017; 1():. PubMed ID: 32913973
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation and urachal remnant pathology: implications for treatment.
Copp HL; Wong IY; Krishnan C; Malhotra S; Kennedy WA
J Urol; 2009 Oct; 182(4 Suppl):1921-4. PubMed ID: 19695622
[TBL] [Abstract][Full Text] [Related]
13. Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.
Módos O; Reis H; Niedworok C; Rübben H; Szendröi A; Szász MA; Tímár J; Baghy K; Kovalszky I; Golabek T; Chlosta P; Okon K; Peyronnet B; Mathieu R; Shariat SF; Hollósi P; Nyirády P; Szarvas T
Oncotarget; 2016 Jun; 7(26):39293-39301. PubMed ID: 27283768
[TBL] [Abstract][Full Text] [Related]
14. A remnant never forgotten: the utility of circulating tumor DNA in treatment guidance of urachal cancer.
Grant CR; Benjamin DJ; Cramer S; Rezazadeh Kalebasty A
Ther Adv Med Oncol; 2024; 16():17588359241230743. PubMed ID: 38425988
[TBL] [Abstract][Full Text] [Related]
15. Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis.
Riva G; Mian C; Luchini C; Girolami I; Ghimenton C; Cima L; Novelli L; Hanspeter E; Mazzoleni G; Schwienbacher C; Pycha S; D'Elia C; Trenti E; Pycha A; Martignoni G; Hes O; Eccher A; Nesi G; Brunelli M
Virchows Arch; 2019 Jan; 474(1):13-20. PubMed ID: 30302546
[TBL] [Abstract][Full Text] [Related]
16. Infected urachal cyst in an adult, report of two observations.
Faye PM; Gueye ML; Thiam O; Niasse A; Ndong A; Ndiaye M; Seye Y; Sarr ISS; Seck M; Toure AO; Cisse M
Int J Surg Case Rep; 2022 Aug; 97():107394. PubMed ID: 35834928
[TBL] [Abstract][Full Text] [Related]
17. Urachal cyst with xanthogranulomatous cystitis: A rare case report.
Singh A; Kishan Prasad HL; Shetty KJ; Philip NR; Salma R; Chakravarthy A
Urol Ann; 2018; 10(2):219-221. PubMed ID: 29719338
[TBL] [Abstract][Full Text] [Related]
18. Infected urachal cyst in an adult: A case report.
Mrad Daly K; Ben Rhouma S; Zaghbib S; Oueslati A; Gharbi M; Nouira Y
Urol Case Rep; 2019 Sep; 26():100976. PubMed ID: 31380223
[TBL] [Abstract][Full Text] [Related]
19. Imaging of urachal anomalies.
Buddha S; Menias CO; Katabathina VS
Abdom Radiol (NY); 2019 Dec; 44(12):3978-3989. PubMed ID: 31478084
[TBL] [Abstract][Full Text] [Related]
20. Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas.
Varadi M; Nagy N; Reis H; Hadaschik B; Niedworok C; Modos O; Szendroi A; Ablat J; Black PC; Keresztes D; Csizmarik A; Olah C; Gaisa NT; Kiss A; Timar J; Toth E; Csernak E; Gerstner A; Mittal V; Karkampouna S; Kruithof de Julio M; Gyorffy B; Bedics G; Rink M; Fisch M; Nyirady P; Szarvas T
Cancer Med; 2023 Apr; 12(7):9041-9054. PubMed ID: 36670542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
